Rossari Biotech Ltd posts consolidated PAT of Rs. 33.59 crores in Q1 FY26

Rossari Biotech Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 544.916 crores during the period ended June 30, 2025 as compared to Rs. 581.353 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 33.596 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 34.444 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 6.06 for the period ended June 30, 2025 as compared to Rs. 6.21 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 544.916 crs	₹581.353 crs	-6.27%
Net Profit	₹33.596 crs	₹34.444 crs	-2.46%
EPS	₹6.06	₹6.21	-2.42%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 544.916 crores during the period ended June 30, 2025 as compared to Rs.490.598 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.33.596 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.34.899 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.6.06 for the period ended June 30, 2025 as compared to Rs.6.30 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 544.916 crs	₹490.598 crs	11.07%
Net Profit	₹33.596 crs	₹34.899 crs	-3.73%
EPS	₹6.06	₹6.30	-3.81%

Shares of Rossari Biotech Limited was last trading in BSE at Rs. 742.80 as compared to the previous close of Rs. 739.70. The total number of shares traded during the day was 10900 in over 770 trades.

The stock hit an intraday high of Rs. 745.00 and intraday low of 729.40. The net turnover during the day was Rs. 8040620.00.

Source : Equity Bulls

Keywords

RossariBiotech Q1FY26 Q1FY2026 FY2026 ResultUpdate